相关实验视频

Updated: Jul 2, 2025

Developing a Rat Model for Bipolar Disorder

Developing a Rat Model for Bipolar Disorder

Published on: May 2, 2025

双相II型精神障碍潜在的诊断生物标志物 (循环miRNA和蛋白质) 的相关性

Kuo-Wang Tsai¹, Yi-Fang Yang², Liang-Jen Wang³

¹Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei, Taiwan.

Journal of psychiatric research

|February 27, 2024

概括

外围生物标记物,包括特定的微RNA (miRNA) 和蛋白质,在双相二极性障碍 (BD-II) 中显示出显著的相关性. 这些发现表明,潜在的相互作用轴,miR-221-5p/CA-1/MMP9和miR-370-3p/FARSB/PCSK9,参与了BD-II病理机制.

科学领域:

生物化学生物化学
分子生物学分子生物学
精神病学是一个精神病学.

背景情况:

二极性II型障碍 (BD-II) 是一种情绪障碍,具有复杂的病理生理学.
包括循环中的微RNA (miRNA) 和蛋白质在内的外围生物标志物已被确定为BD-II的潜在指标.
之前的研究已经确定了与BD-II相关的特定miRNAs (miR-7-5p,miR-142-3p,miR-221-5p,miR-370-3p) 和蛋白质 (MMP9,FARSB,PRDX2,CA-1,PCSK9).

研究的目的:

探索之前在BD-II患者中发现的外周循环miRNA和蛋白质之间的相关性.
使用生物信息学工具调查这些生物标志物之间的潜在相互作用.
阐明这些生物标志物相互作用在BD-II病理机制中的作用.

主要方法:

在BD-II患者 (N=96) 和对照组 (N=115) 中,对循环miRNA和蛋白质的外周水平进行了相关性分析.
生物信息工具 (TargetScan,BioGrid) 用于识别蛋白质编码基因和循环miRNAs之间的直接和间接相互作用.
对于观察到的相关性,确定了统计学意义.

主要成果:

在BD-II组中,在miR-221-5p和CA-1,FARSB,MMP-9和PCSK9之间发现了显著的相关性.
在BD-II组中,miR-370-3p还与FARSB和PCSK9表达有显著的相关性.
发现的相关性与预测的调节轴一致:miR-221-5p/CA-1/MMP9和miR-370-3p/FARSB/PCSK9.

结论:

边缘候选miRNAs和蛋白质在BD-II.II的背景下相互作用.
建议miR-221-5p/CA-1/MMP9和miR-370-3p/FARSB/PCSK9轴在BD-II的病理机制中发挥关键作用.
这些发现有助于了解BD-II的分子基础,并可能提供潜在的诊断或治疗点.

关键词:

生物标志物生物标志物双极性II型障碍是一种双极性II型障碍.相对应关系相对应关系蛋白质蛋白质是一种蛋白质.这是一个小RNARNA.

更多相关视频

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment

Published on: July 7, 2023

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

相关概念视频

Bipolar Disorder

Bipolar Disorder

Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.

Mania and Antimanic Drugs: Overview

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...